$3.86
5.18%
Nasdaq, Sep 12, 10:12 pm CET
ISIN
US67022C1062
Symbol
NCNA

NuCana plc Sponsored ADR Stock price

$3.86
-0.85 18.05% 1M
-158.34 97.62% 6M
-234.14 98.38% YTD
-506.14 99.24% 1Y
-7,596.14 99.95% 3Y
-27,546.14 99.99% 5Y
-80,746.14 100.00% 10Y
-80,746.14 100.00% 20Y
Nasdaq, Closing price Fri, Sep 12 2025
+0.19 5.18%
ISIN
US67022C1062
Symbol
NCNA
Industry

Key metrics

Basic
Market capitalization
$7.0m
Enterprise Value
$1.9m
Net debt
positive
Cash
$5.4m
Shares outstanding
151.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
1.2
Financial Health
Equity Ratio
40.3%
Return on Equity
-319.1%
ROCE
-404.8%
ROIC
-286.4%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-23.1m | -
EBIT
$-23.7m | $-38.4m
Net Income
$-19.8m | $-1.5b
Free Cash Flow
$-22.5m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
45.1% | -
EBIT
44.6% | -23.1%
Net Income
45.0% | -5,849.5%
Free Cash Flow
25.9%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-0.1
FCF per Share
$-0.1
Short interest
0.0%
Employees
21
Rev per Employee
$0.0
Show more

Is NuCana plc Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

NuCana plc Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a NuCana plc Sponsored ADR forecast:

6x Buy
75%
2x Hold
25%

Analyst Opinions

8 Analysts have issued a NuCana plc Sponsored ADR forecast:

Buy
75%
Hold
25%

Financial data from NuCana plc Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 6.07 6.07
25% 25%
-
- Research and Development Expense 18 18
48% 48%
-
-23 -23
45% 45%
-
- Depreciation and Amortization 0.61 0.61
21% 21%
-
EBIT (Operating Income) EBIT -24 -24
45% 45%
-
Net Profit -20 -20
45% 45%
-

In millions USD.

Don't miss a Thing! We will send you all news about NuCana plc Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

NuCana plc Sponsored ADR Stock News

Neutral
GlobeNewsWire
10 days ago
EDINBURGH, United Kingdom, Sept. 05, 2025 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq: NCNA) (“NuCana” or the “Company”) announced that it has received formal notification from The Nasdaq Stock Market on September 4, 2025 confirming that the Company is in compliance with all applicable Nasdaq continued listing criteria, including the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550...
Neutral
GlobeNewsWire
12 days ago
EDINBURGH, United Kingdom, Sept. 03, 2025 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq: NCNA) (“NuCana” or the “Company”) announced a presentation at the upcoming annual European Society for Medical Oncology (“ESMO”) congress being held October 17-21, 2025 in Berlin, Germany (the “ESMO Congress 2025”).
Neutral
GlobeNewsWire
26 days ago
First Patients Dosed on Expansion Study of NUC-7738 in Combination with Pembrolizumab for Patients with PD-1 Inhibitor-Resistant Melanoma
More NuCana plc Sponsored ADR News

Company Profile

NuCana Plc engages in the development of technology platform for the treatment of patients with cancer. Its Protide technology consists of acelarin, NUC-3373 and NUC-7738. The company was founded by Hugh S. Griffith and Christopher B. Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.

Head office United Kingdom
CEO Hugh Griffith
Employees 21
Founded 1997
Website www.nucana.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today